Morphocell Technologies
Vincent Ling is an experienced professional in the fields of business development and innovation, currently serving as the Chief Business Officer at Morphocell Technologies. Previously, Vincent held the position of Consultant Advisor at the Bill & Melinda Gates Foundation and served as Senior Director of the Center for External Innovation at Takeda Pharmaceuticals. Additionally, Vincent was the Head of Biological Sciences for Encapsulated Cell Therapy at Neurotech Pharmaceuticals, Inc., and functioned as Vice President at Dragonfly Sciences, Inc.
This person is not in any teams
This person is not in any offices
Morphocell Technologies
Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissues targeting liver failure. The Company is a spin-off of the Hepatology and Cell Therapy lab of Sainte-Justine University Hospital Center, in Montreal. Founded in April 2018 on the technology developed by Dr.Paganelli, a pediatric transplant hepatologist and stem cell scientist, Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure.